128 related articles for article (PubMed ID: 14764070)
21. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery.
Kim S; Izumi Y; Yano M; Hamaguchi A; Miura K; Yamanaka S; Miyazaki H; Iwao H
Circulation; 1998 May; 97(17):1731-7. PubMed ID: 9591768
[TBL] [Abstract][Full Text] [Related]
24. Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts.
Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI
J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):285-96. PubMed ID: 14740078
[TBL] [Abstract][Full Text] [Related]
25. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.
van Eickels M; Grohé C; Cleutjens JP; Janssen BJ; Wellens HJ; Doevendans PA
Circulation; 2001 Sep; 104(12):1419-23. PubMed ID: 11560859
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts.
Johnsen DD; Kacimi R; Anderson BE; Thomas TA; Said S; Gerdes AM
Mol Cell Biochem; 2005 Feb; 270(1-2):63-9. PubMed ID: 15792354
[TBL] [Abstract][Full Text] [Related]
27. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
[TBL] [Abstract][Full Text] [Related]
28. Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats.
Izumi Y; Kim S; Murakami T; Yamanaka S; Iwao H
Hypertension; 1998 Jan; 31(1):50-6. PubMed ID: 9449390
[TBL] [Abstract][Full Text] [Related]
29. Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo.
Kim L; Lee T; Fu J; Ritchie ME
Am J Physiol; 1999 Nov; 277(5):H1808-16. PubMed ID: 10564134
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes.
Adams JW; Sah VP; Henderson SA; Brown JH
Circ Res; 1998 Jul; 83(2):167-78. PubMed ID: 9686756
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
33. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Wakui H; Tamura K; Tanaka Y; Matsuda M; Bai Y; Dejima T; Masuda S; Shigenaga A; Maeda A; Mogi M; Ichihara N; Kobayashi Y; Hirawa N; Ishigami T; Toya Y; Yabana M; Horiuchi M; Minamisawa S; Umemura S
Hypertension; 2010 May; 55(5):1157-64. PubMed ID: 20231526
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
35. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.
Zhong Z; Davidescu A; Ehrén I; Ekberg K; Jörnvall H; Wahren J; Chibalin AV
Diabetologia; 2005 Jan; 48(1):187-97. PubMed ID: 15624099
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats.
Kishi T; Hirooka Y; Konno S; Ogawa K; Sunagawa K
Hypertension; 2010 Feb; 55(2):291-7. PubMed ID: 20065158
[TBL] [Abstract][Full Text] [Related]
37. Reduction of angiotensin II-induced activation of mitogen-activated protein kinase in cardiac hypertrophy.
Rabkin SW; Sunga PS; Sanghera JS; Pelech SL
Cell Mol Life Sci; 1997 Dec; 53(11-12):951-9. PubMed ID: 9447248
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of cardiac hypertrophy.
Yamazaki T; Yazaki Y
Z Kardiol; 2000 Jan; 89(1):1-6. PubMed ID: 10663910
[TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion.
Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI
Mol Cell Biochem; 2004 Mar; 258(1-2):211-8. PubMed ID: 15030186
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?
Clerk A; Michael A; Sugden PH
J Cell Biol; 1998 Jul; 142(2):523-35. PubMed ID: 9679149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
